NHS England is getting a breakthrough HIV drug – but the rest of the world needs it too
- Posted on August 21, 2026
- By The Independent
- 1 Views
- 1 min read
In brief
Lenacapavir represents a significant advancement in HIV treatment, with NHS England now providing access to this innovative antiretroviral therapy. However, a critical disparity exists as vulnerable populations in developing nations, whose communities contributed to clinical research, remain unable to afford or access this life-saving medication. This raises important questions about global health equity and pharmaceutical accessibility in underserved regions.
Summary auto-generated by AI from the original publisher's content. Editorial standards.
NHS England is getting a breakthrough HIV drug – but the rest of the world needs it too
Game-changing HIV drug Lenacapavir will soon be saving lives across the country, writes Molly Thompson, yet marginalised communities in the global south who made this possible still don’t have access
